Eiko Lifesciences Ltd

BSE :540204 NSE :- Sector : Chemica..
53.40
Change: 2.30(4.50%)
52 week Low
44.99
52 week High
74.88
Day low
51.25
Day high
55.20
Prev Close
51.10
Open
51.25
6M return
-12.00%
1Y return
-14.63%
MCap(Rs. in Cr.)
63.62
Total Volume
11,040
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
54.95
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
0.93
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
1.31
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
88.71%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.00

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales
9.92%

Sales Industry Avg
12.46%

PAT
5.63%

PAT Industry Avg
-33.23%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales6.917.7410.758.4027.93
Gross Profit0.530.440.630.601.65
Operating Profit00000
Profit Before Tax0.350.260.440.410.98
Tax0.070.050.090.100.23
Profit After Tax0.280.210.350.310.75
Growth in 3 years

Total Asset Growth
-111.22%

Total Liabilities growth
-63.70%

Reserves Change
-150.00%

Mar 2020
( in Cr.)
Mar 2019
( in Cr.)
Mar 2018
( in Cr.)
Share Capital3.823.823.82
Reserves And Surplus-0.871.101.74
Investments0.101.723.17
Total Debt1.611.371.74
Total Liabilities2.736.177.52
Total Assets-0.834.747.40
No data available


Relative to Sensex rtn in 3 year
-68.28%

Relative to Nifty rtn in 3 year
-69.66%



1 Year (%)2 Year (%)3 Year (%)
Eiko Lifescience-15-2210
Bse Sensex42531
Nifty 5042933

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Eiko Lifescience
53.40
Change: 2.30 (4.50%)
1 Year return
-14.63%
Risk (Std Dev)
0.13%
PE Ratio
54.95
MCap( in Cr.)
63.62
Transpek Inds.
1,315.00
Change: -20.45 (-1.53%)
1 Year return
-32.50%
Risk (Std Dev)
0.06%
PE Ratio
21.23807
MCap( in Cr.)
745.92
Primo Chemicals
28.97
Change: -0.12 (-0.41%)
1 Year return
-32.72%
Risk (Std Dev)
0.15%
PE Ratio
63.23913
MCap( in Cr.)
704.98
Vikram Thermo
198.05
Change: -1.95 (-0.97%)
1 Year return
33.64%
Risk (Std Dev)
0.11%
PE Ratio
19.59
MCap( in Cr.)
627.16
Nitta Gelatin
679.95
Change: 20.00 (3.03%)
1 Year return
-28.16%
Risk (Std Dev)
0.07%
PE Ratio
8.18593
MCap( in Cr.)
599.23
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 85,371.70 with a Loss of -14.63%

News

Stay tuned to the latest developments and happenings in the company.

Eiko Lifesciences standalone net profit rises 16.67% in the December 2024 quarter

Net profit of Eiko Lifesciences rose 16.67% to Rs 0.28 crore in the quarter ended December 2024 as against Rs 0.24 crore during the previous quarter e....

13 Feb 2025 08:08

Eiko Lifesciences to discuss results

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live News<....

24 Jan 2025 15:58

Eiko Lifesciences to conduct board meeting

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 25 November 2024Powered by Capital Market - Live News</....

20 Nov 2024 09:51

Eiko Lifesciences standalone net profit rises 75.00% in the September 2024 quarter

Net profit of Eiko Lifesciences rose 75.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarter ....

21 Oct 2024 07:32

Eiko Lifesciences to discuss results

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live News</....

14 Oct 2024 10:24

Eiko Lifesciences standalone net profit rises 337.50% in the June 2024 quarter

Net profit of Eiko Lifesciences rose 337.50% to Rs 0.35 crore in the quarter ended June 2024 as against Rs 0.08 crore during the previous quarter ende....

14 Aug 2024 07:40

View More
Subscribe for our
newsletter
Open Account Now